Rectal cancer
Drug research and approvals for rectal cancer: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 1,295 studies of rectal cancer are recruiting on ClinicalTrials.gov, and Health Canada has authorized 8 drug trials for it since 2013.
- Recruiting worldwide: 1,295
- Trials authorized in Canada: 8
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 1,295 recruiting on ClinicalTrials.gov ↗- Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard…NCT07551596 · Phase 2 · National Cancer Institute (NCI) · starts May 25, 2027
- A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal…NCT06424522 · Not applicable · Ohio State University Comprehensive Cancer Center · starts Feb 15, 2027
- Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or…NCT07271355 · Phase 3 · City of Hope Medical Center · starts Jan 4, 2027
- Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)NCT07433673 · Phase 2 · Columbia University · starts Jan 1, 2027
- Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal…NCT07750158 · Phase 3 · Exelixis · starts Dec 18, 2026
- Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for…NCT07790718 · Not applicable · City of Hope Medical Center · starts Dec 16, 2026
- SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-METNCT07873450 · Phase 1 / Phase 2 · Full-Life Technologies UK Limited · starts Dec 1, 2026
- Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal CancerNCT07759921 · Not applicable · University of Colorado, Denver · starts Dec 1, 2026
- TCR1188-ABC Cells in KRAS-mutated CancersNCT07594067 · Phase 1 · University of Pennsylvania · starts Dec 1, 2026
- Single Versus Double Stapling and Two Purse-String Techniques in Rectal Cancer SurgeryNCT07929415 · Not applicable · Alexandria University · starts Nov 5, 2026
Trials Authorized in Canada
Newest first; search them all in Canada trials| Jun 9, 2026 | Pilot evaluation of the immunogenic potentiation of neo-adjuvant brachytherapy followed by nivolumab immunotherapy without chemotherapy in stage ii/iii locally…OPDIVO (NIVOLUMAB) | SIR MORTIMER B. DAVIS JEWISH GENERAL HOSPITAL (CIUSSS CCOMTL, SANTÉ QUÉBEC) | Ongoing |
| Mar 1, 2024 | A phase 3 randomized trial of neoadjuvant chemotherapy, excision and observation versus chemoradiotherapy for early rectal cancerCAPECITABINE/ FLUOROURACIL/ LEUCOVORIN/ OXALIPLATIN | CANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITY | Ongoing |
| Nov 3, 2023 | 18fdg-pet/mri imaging in predicting pathological response to total neo-adjuvant therapy in rectal cancer18F-FLUORODEOXYGLUCOSE | CROSS CANCER INSTITUTE - CANCER CARE ALBERTA | Pending |
| May 3, 2023 | Colon adjuvant chemotherapy based on evaluation of residual disease (circulate-us)IRINOTECAN | CANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITY | Ongoing |
| Dec 22, 2020 | Circulating tumor dna analysis informing adjuvant chemotherapy in stage iii colon cancer: a multicentre phase II/iii randomised controlled study (dynamic iii)IRINOTECAN | CANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITY | Ongoing |
| Sep 16, 2020 | A multicenter study with an open-label phase Ib part followed by a randomized, placebo-controlled, double-blind, phase II part to evaluate efficacy, safety,…PEPOSERTIB (M3814) | Merck KGaA | Pending |
| Jun 20, 2016 | Metformin with neoadjuvant chemoradiation (crt) to improve pathologic responses in rectal cancer: an internal pilot study.METFORMIN | SUNNYBROOK RESEARCH INSTITUTE | Closed |
| Jan 20, 2016 | 18f-fluoroazomycin arabinoside (faza) positron emission tomography / magnetic resonance imaging (pet/mr) as a biomarker of hypoxia in rectal cancer: a pilot…[F-18]-FAZA INJECTION ([F-18]-FLUOROAZOMYCIN ARABINOSIDE) / PIMONIDAZOLE… | UNIVERSITY HEALTH NETWORK | Ongoing |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA